T1	location 95 101	Mexico
T2	total-participants 726 728	20
T3	eligibility 729 815	patients with diagnosis of breast cancer and out of oncological therapeutic processing
T4	intervention 49 76	inhibitors of the aromatase
T5	control 80 89	tamoxifen
T6	intervention-participants 910 912	10
T7	control-participants 939 941	10
T9	outcome 1175 1191	ductal carcinoma
T10	cv-bin-percent 1195 1198	70%
T11	iv-bin-percent 1263 1266	90%
T12	outcome 1272 1305	mastectomy prior to the tamoxifen
T13	iv-bin-percent 1325 1328	60%
T14	cv-bin-percent 1352 1355	50%
T15	outcome 1464 1472	complete
T16	cv-bin-percent 1480 1483	60%
T17	iv-bin-percent 1534 1537	80%
T18	outcome 1539 1547	survival
T19	iv-bin-percent 1585 1589	100%
T20	cv-bin-percent 1673 1676	90%
T8	outcome 1724 1732	survival
T21	outcome 1748 1763	quality of life
